Vanc portfolio From Vancs corporate presentation, Vanc plans on expanding portfolio through acquiring higher margin products via co-development and exclusive licensing of ophthalamic products, injectables, and skin care.
If you read RP news from jan 11 2016 i think we can all agree that company is executing their business plan and Mr. David Hall is a huge addition to Vanc
https://www.stockhouse.com/news/press-releases/2016/01/11/replicel-receives-european-patent-for-its-innovative-dermal-injector-technology